Q3  2024 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 9.59% |
68,646 |
0.50 |
≡ |
ValueAct Capital |
Reduce 23.63% |
806,962 |
2.73 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
7,836 |
0.02 |
Q2  2024 |
≡ |
Lee Ainslie - Maverick Capital |
Add 81.22% |
3,512 |
0.01 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 1.87% |
13,619 |
0.09 |
Q1  2024 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
4,324 |
0.01 |
≡ |
ValueAct Capital |
Reduce 19.69% |
837,000 |
2.54 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 22.01% |
205,896 |
1.38 |
≡ |
Bill Miller - Miller Value Partners |
Sell 100.00% |
5,000 |
0.46 |
Q4  2023 |
≡ |
ValueAct Capital |
Buy |
4,251,568 |
12.92 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 3.66% |
35,547 |
0.29 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 66.67% |
10,000 |
0.92 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
22,092 |
0.05 |
Q3  2023 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 7.06% |
64,046 |
0.39 |
≡ |
Bill Miller - Miller Value Partners |
Buy |
15,000 |
0.99 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 86.84% |
145,750 |
0.33 |
≡ |
Michael Burry - Scion Asset Management |
Sell 100.00% |
100,000 |
9.82 |
Q2  2023 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 594.48% |
776,391 |
4.73 |
≡ |
Lee Ainslie - Maverick Capital |
Add 26.71% |
35,383 |
0.08 |
≡ |
Michael Burry - Scion Asset Management |
Buy |
100,000 |
9.82 |
≡ |
Bill Miller - Miller Value Partners |
Sell 100.00% |
778,059 |
4.72 |
Q1  2023 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 1.08% |
1,425 |
0.06 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 1.17% |
9,241 |
0.06 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 31.13% |
59,878 |
0.15 |
Q4  2022 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 4.62% |
5,825 |
0.25 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 1.22% |
2,382 |
0.01 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 1.74% |
13,973 |
0.08 |
Q3  2022 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 37.06% |
34,125 |
1.62 |
≡ |
Bill Miller - Miller Value Partners |
Add 29.94% |
184,605 |
1.05 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 22.53% |
56,620 |
0.12 |
Q2  2022 |
≡ |
Samantha McLemore - Patient Capital Management |
Buy |
92,075 |
4.28 |
≡ |
Bill Miller - Miller Value Partners |
Buy |
616,668 |
3.28 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 1.62% |
4,150 |
0.01 |
Q1  2022 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 15.72% |
47,662 |
0.17 |
≡ |
Daniel Loeb - Third Point |
Sell 100.00% |
1,307,359 |
1.65 |
Q4  2021 |
≡ |
Lee Ainslie - Maverick Capital |
Add 36.43% |
80,950 |
0.18 |
≡ |
Daniel Loeb - Third Point |
Buy |
1,307,359 |
1.65 |
≡ |
David Einhorn - Greenlight Capital |
Sell 100.00% |
20,000 |
0.22 |
Q3  2021 |
≡ |
Lee Ainslie - Maverick Capital |
Add 14.86% |
28,740 |
0.05 |
≡ |
David Einhorn - Greenlight Capital |
Reduce 50.00% |
20,000 |
0.22 |
Q2  2021 |
≡ |
Lee Ainslie - Maverick Capital |
Add 983.03% |
175,598 |
0.27 |
≡ |
David Einhorn - Greenlight Capital |
Buy |
40,000 |
0.41 |
Q1  2021 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
17,863 |
0.03 |
≡ |
Daniel Loeb - Third Point |
Sell 100.00% |
1,200,000 |
1.22 |
Q4  2020 |
≡ |
Daniel Loeb - Third Point |
Reduce 26.15% |
425,000 |
0.43 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
7,969 |
0.01 |
Q3  2020 |
≡ |
Daniel Loeb - Third Point |
Buy |
1,625,000 |
1.50 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 71.36% |
19,858 |
0.02 |
Q2  2020 |
≡ |
Lee Ainslie - Maverick Capital |
Add 5510.28% |
27,331 |
0.05 |
≡ |
Christopher Davis - Davis Advisors |
Sell 100.00% |
85,682 |
0.03 |
Q1  2020 |
≡ |
Christopher Davis - Davis Advisors |
Reduce 1.61% |
1,400 |
0.00 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 98.79% |
40,383 |
0.00 |
Q4  2019 |
≡ |
Lee Ainslie - Maverick Capital |
Add 14.25% |
5,100 |
0.01 |
Q3  2019 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 14.01% |
5,831 |
0.01 |
Q2  2019 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 7.18% |
3,220 |
0.01 |
Q1  2019 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 0.33% |
150 |
0.00 |
≡ |
Steven Romick - FPA Crescent Fund |
Sell 100.00% |
1,142,570 |
1.35 |
Q4  2018 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 8.05% |
3,940 |
0.01 |
≡ |
Steven Romick - FPA Crescent Fund |
Reduce 35.91% |
640,101 |
0.76 |
Q3  2018 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 16.70% |
9,810 |
0.02 |
≡ |
Steven Romick - FPA Crescent Fund |
Reduce 22.26% |
510,495 |
0.56 |
Q2  2018 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 31.55% |
27,070 |
0.04 |
Q1  2018 |
≡ |
Lee Ainslie - Maverick Capital |
Add 59.84% |
32,120 |
0.04 |
≡ |
Steven Romick - FPA Crescent Fund |
Add 12.69% |
258,263 |
0.25 |
≡ |
Leon Cooperman |
Sell 100.00% |
195,497 |
0.89 |
Q4  2017 |
≡ |
Lee Ainslie - Maverick Capital |
Add 126.98% |
30,030 |
0.04 |
≡ |
Steven Romick - FPA Crescent Fund |
Buy |
2,034,903 |
2.08 |
≡ |
Stephen Mandel - Lone Pine Capital |
Sell 100.00% |
4,656,018 |
3.30 |
Q3  2017 |
≡ |
Stephen Mandel - Lone Pine Capital |
Add 2.93% |
132,404 |
0.09 |
≡ |
Leon Cooperman |
Buy |
195,497 |
1.10 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
23,650 |
0.04 |
≡ |
David Tepper - Appaloosa Management |
Sell 100.00% |
200,000 |
0.47 |
Q2  2017 |
≡ |
Stephen Mandel - Lone Pine Capital |
Add 113.19% |
2,401,713 |
1.82 |
≡ |
David Tepper - Appaloosa Management |
Buy |
200,000 |
0.47 |
Q1  2017 |
≡ |
Stephen Mandel - Lone Pine Capital |
Reduce 50.85% |
2,195,631 |
1.46 |
Q4  2016 |
≡ |
Stephen Mandel - Lone Pine Capital |
Reduce 39.56% |
2,825,799 |
1.68 |
Q3  2016 |
≡ |
Stephen Mandel - Lone Pine Capital |
Buy |
7,143,331 |
3.73 |
Q1  2016 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
2,140 |
0.00 |
Q4  2015 |
≡ |
Stephen Mandel - Lone Pine Capital |
Sell 100.00% |
1,094,269 |
0.58 |
Q3  2015 |
≡ |
Stephen Mandel - Lone Pine Capital |
Buy |
1,094,269 |
0.58 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 12.65% |
310 |
0.00 |
Q2  2015 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 16.38% |
480 |
0.00 |
Q1  2015 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
2,930 |
0.00 |
Q3  2014 |
≡ |
David Tepper - Appaloosa Management |
Sell 100.00% |
897,137 |
1.08 |
Q2  2014 |
≡ |
David Tepper - Appaloosa Management |
Add 28.93% |
201,300 |
0.24 |
Q1  2014 |
≡ |
David Tepper - Appaloosa Management |
Buy |
695,837 |
0.88 |
Q3  2012 |
≡ |
David Einhorn - Greenlight Capital |
Sell 100.00% |
988,000 |
0.80 |
Q2  2012 |
≡ |
David Einhorn - Greenlight Capital |
Reduce 1.20% |
12,000 |
0.01 |
Q1  2012 |
≡ |
David Einhorn - Greenlight Capital |
Buy |
1,000,000 |
0.65 |
≡ |
Bill & Melinda Gates Foundation Trust |
Sell 100.00% |
750,000 |
0.14 |
Q4  2011 |
≡ |
Bill & Melinda Gates Foundation Trust |
Reduce 50.00% |
750,000 |
0.14 |
≡ |
David Katz - Matrix Asset Advisors |
Sell 100.00% |
34,000 |
1.18 |
Q3  2011 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 5.56% |
2,000 |
0.07 |
Q2  2011 |
≡ |
David Katz - Matrix Asset Advisors |
Reduce 20.00% |
9,000 |
0.27 |
Q1  2011 |
≡ |
David Katz - Matrix Asset Advisors |
Buy |
45,000 |
0.94 |
Q1  2010 |
≡ |
Bill & Melinda Gates Foundation Trust |
Buy |
1,500,000 |
0.30 |
Q2  2007 |
≡ |
Wallace Weitz - Weitz Large Cap Equity Fund |
Sell 100.00% |
2,100,000 |
1.79 |
Q1  2007 |
≡ |
Wallace Weitz - Weitz Large Cap Equity Fund |
Reduce 40.00% |
1,400,000 |
1.19 |